Does selective serotonin reuptake inhibitor (SSRI) fluoxetine affects mussel Mytilus galloprovincialis?

Environ Pollut. 2013 Feb:173:200-9. doi: 10.1016/j.envpol.2012.10.018. Epub 2012 Nov 29.

Abstract

Fluoxetine (FLX) the active pharmaceutical ingredient (API) in Prozac(®) is a widely prescribed psychoactive drug which ubiquitous occurrence in the aquatic environment is associated to a poor removal rate in waste-water treatment plant (WWTP) systems. This API acts as a selective serotonin reuptake inhibitor (SSRI) frequently reported to cause disrupting effects in non-target species. The objective of this study includes a multibiomarker response evaluation on mussel Mytilus galloprovincialis during two weeks exposure to 75 ng L(-1) FLX assessing antioxidant enzymes activities--superoxide dismutase (SOD), catalase (CAT) and glutathione-S-transferase (GST); lipid peroxidation (LPO), acetylcholinesterase (AChE) neurotoxic response and endocrine disruption through alkali-labile phosphates (ALP) indirect measurement of vitellogenin-like proteins. Results show transient tissue-specific enzymatic responses and damage affecting mostly mussel gills. However, the clear ALP levels inhibition throughout time in both sex-differentiated gonads gives evidence to FLX reinforced action as an endocrine disruptor rather than an oxidative or neurotoxic inducer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholinesterase / metabolism
  • Animals
  • Catalase / metabolism
  • Endocrine Disruptors / toxicity
  • Female
  • Fluoxetine / toxicity*
  • Glutathione Transferase / metabolism
  • Lipid Peroxidation / drug effects
  • Male
  • Mytilus
  • Superoxide Dismutase / metabolism
  • Water Pollutants, Chemical / toxicity*

Substances

  • Endocrine Disruptors
  • Water Pollutants, Chemical
  • Fluoxetine
  • Catalase
  • Superoxide Dismutase
  • Glutathione Transferase
  • Acetylcholinesterase